Literature DB >> 12663165

Development and evaluation of the nuclisens basic kit NASBA for the detection of RNA from Candida species frequently resistant to antifungal drugs.

Juergen Loeffler1, Christiane Dorn, Holger Hebart, Philipp Cox, Stella Magga, Hermann Einsele.   

Abstract

We describe a Nucleic Acid Sequence Based Amplification (NASBA) protocol to detect 6 different Candida species (Candida krusei, Candida glabrata, Candida inconspicua, Candida dubliniensis, Candida norvegensis, Candida lusitaniae) and compare it to a PCR assay. NASBA showed a sensitivity of 1 Colony Forming Unit and detected RNA from all 6 Candida species within 1 working day. All 5 patients with documented candidiasis showed identical results by both methods. This assay offers a sensitive, specific and fast possibility to detect yeast RNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663165     DOI: 10.1016/s0732-8893(02)00510-2

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  3 in total

1.  Efficient identification of clinically relevant Candida yeast species by use of an assay combining panfungal loop-mediated isothermal DNA amplification with hybridization to species-specific oligonucleotide probes.

Authors:  João Inácio; Orfeu Flores; Isabel Spencer-Martins
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

2.  Rapid real-time nucleic Acid sequence-based amplification-molecular beacon platform to detect fungal and bacterial bloodstream infections.

Authors:  Yanan Zhao; Steven Park; Barry N Kreiswirth; Christine C Ginocchio; Raphaël Veyret; Ali Laayoun; Alain Troesch; David S Perlin
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

Review 3.  Antifungal drug resistance: do molecular methods provide a way forward?

Authors:  David S Perlin
Journal:  Curr Opin Infect Dis       Date:  2009-12       Impact factor: 4.915

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.